It's almost definitely an insurance scalping strategy, and the number of people needing this drug via this delivery route may actually be that small (or close t

It's almost definitely an insurance scalping strategy, and the number of people needing this drug via this delivery route may actually be that small (or close to it). When companies do this, they usually just hand it out to uninsured patients for cheap or free, not out of the goodness of their hearts but because they want to try and reduce bad PR. The whole Martin Shkreli debacle was incredibly similar, and in the same way that people couldn't seem to talk rationally about the real problem there (high pricing encouraging more high pricing just because insurance will pay for it), the average discussion about this case of pharmaceutical scalping will completely miss the point, too.